Dr. Weili Wang
Case Western Reserve University, USA
Email: wxw336@case.edu
Qualifications
2014 Ph.D., Norman
Bethune College of Medicine, Jilin University, China
2005 M.Sc., Norman Bethune
College of Medicine, Jilin University, China
Publications (Selected)
-
Yu H, Lam K-O,
Green MD, Wu H, Yang L, Wang W, Jin J-Y, Hu C, Wang Y, Jolly S, Kong F-M:
Significance of Radiation Esophagitis: Conditional Survival Assessment in
Patients with Non-Small Cell Lung Cancer. Journal of the National Cancer
Center, 2021
-
Zhang H, Wang
W, Pi W, Bi N, DesRosierse C, Kong V, Cheng M, Yang L, Jolly S, Jin J, Kong F:
Genetic variations in the transforming growth factor-β1 pathway may improve
predictive power for overall survival in non-small cell lung cancer. Frontiers
in Oncology, 2021 (In Press)
-
Jin J-Y, Gu A,
Wang W, Oleinick NL, Machtay M, Kong F-M: Ultra-high dose rate effect on
circulating immune cells: A potential mechanism for FLASH effect? Radiotherapy
and Oncology 149:55-62, 2020
-
Wang W,
Matuszak MM, Hu C, Huang KC, Chen E, Arenberg D, Curtis JL, Jolly S, Jin J-Y,
Machtay M, Ten Haken RK, Kong F-M: Central Airway Toxicity After High Dose
Radiation: A Combined Analysis of Prospective Clinical Trials for Non-Small
Cell Lung Cancer. International Journal of Radiation Oncology Biology Physics
108:587-596, 2020.
-
Wang W, Huang
L, Jin J-Y, Pi W, Ellsworth SG, Jolly S, Mellor AL, Machtay M, Kong F-M: A
Validation Study on IDO Immune Biomarkers for Survival Prediction in Non-Small
Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease.
Clinical Cancer Research 26:282-289, 2020.
-
Wang W, Huang
L, Jin J-Y, Jolly S, Zang Y, Wu H, Yan L, Pi W, Li L, Mellor AL, Kong F-M: IDO
Immune Status after Chemoradiation May Predict Survival in Lung Cancer
Patients. Cancer Research 78:809-816, 2018.
-
Wang W, Zhong
W, Chen C, Meng Q, Wei J: Circulating Antibodies to Linear Peptide Antigens
Derived from ANXA1 and FOXP3 in Lung Cancer. Anticancer Research 37:3151-3155,
2017 (Corresponding author).
-
Wang W, Zhong
W, Liu D, Zhang G, Zhou C, Guo G, Liu X: Correlations between patterns of
failure of small cell lung cancer and radiotherapy fraction. Journal of Modern
Oncology 25:216-219, 2017 (Corresponding author).
-
Wang W, Guan
S, Sun S, Jin Y, Lee K-H, Chen Y, Wei J: Detection of circulating antibodies to
linear peptide antigens derived from ANXA1 and DDX53 in lung cancer. Tumor
Biology 35:4901-4905, 2014.
-
Wang W, Xu Y,
Schipper M, Matuszak MM, Ritter T, Cao Y, Ten Haken RK: Effect of normal lung
definition on lung dosimetry and lung toxicity prediction in radiation therapy
treatment planning. International Journal of Radiation Oncology* Biology*
Physics 86:956-963, 2013.
-
Wang W, Ye L,
Li X, Guan S, Sun S, Wang M, Guan X, Lee K-H, Wei J, Liu B: Circulating IgG
antibody against FOXP3 may be a potential biomarker for lung cancer. Advances
in Lung Cancer 2:79, 2013 (Corresponding author).
-
Wang W, Zhou
C, Zhang G, Sun C, Liu X: Correlation between Lactate Dehydrogenase and Neuron
Enolase Levels and Prognosis of Small Cell Lung Cancer before Treatment.
Chinese Journal of Gerontology: 2272-2274, 2013 (Corresponding author).
-
Wang W, Zhang
X, Liu D, Guo G, Zhang X, Liu J: The role of cardiac dosimetry parameters in
predicting radiation heart disease. Chinese Journal of Gerontology
33:2751-2752, 2013 (Corresponding author).
-
Wang W, Pan H,
Zhong W, Guo G, Zhou C, Zhang G: Association of ERCC1 gene polymorphism with
the prognosis of non-small cell lung cancer. Chinese Journal of Laboratory
Diagnosis 17:854-857, 2013 (Corresponding author).
-
Wang W, Liu D,
Guo G, Zhong W, Sun C, Liu X: Study on the relationship between thoracic
radiotherapy segmentation and the prognosis of small cell lung cancer. Chinese
Journal of Laboratory Diagnosis 17:680-682, 2013 (Corresponding author).
-
Wang W, Liu L,
Liu X, Wu Z, Gong S, Shao G: Association of MDM2 Gene Polymorphisms with
Radiosensitivity and Susceptibility to NSCLC. Chinese Journal of Radiation
Oncology: 60-61, 2006.